Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.

Already have a prescription? Search for Ozempic or Wegovy on GoodRx to unlock industry-leading prices as low as $199 per ...

Novo Nordisk AS (NVO) on Monday announced that it will offer its blockbuster obesity and diabetes drugs, Wegovy and Ozempic, ...

(Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced a new, lower cash-pay price for GLP-1 medications, Wegovy ® and Ozempic ®, made possible through its ...

The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling ...

Novo Nordisk today announced that Wegovy® (semaglutide) injection 0.25 mg and 0.5 mg and Ozempic® are now available at a limited time price of $199 per month to new self-pay patients between now and ...

Wegovy, the blockbuster weight-loss drug launched in June, is set to get cheaper in India. Danish drugmaker Novo Nordisk has ...

Danish pharma major Novo Nordisk has slashed the price of Wegovy by up to 37%, to take on its key rival Eli Lilly. Here's how ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh.

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...

Novo Nordisk (NVO stock is in focus as the company cuts prices for Wegovy in India by up to 37% to rival Eli Lilly’s (LLY) Mounjaro. Read more here.

Microsoft Corporation, Eli Lilly and Company, Oracle Corporation, Compagnie Financiere Richemont SA. Read 's Market Analysis on Investing.com ZA.